Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEX-HD trial of dexmedetomidine versus haloperidol for nocturnal hyperactive delirium sedation in non-intubated HDU patients
jRCT1051220015Completed
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in delirium comparing Dexmedetomidine group with Haloperidol group (2 arms). Primary endpoint: Proportion achieving target sedation at 2 hours. Started May 2022; status: completed.
02
Drugs
dexmedetomidinehaloperidol
03
Conditions
delirium
Beyond the preview
Go deeper on jRCT1051220015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051220015.